Results 211 to 220 of about 144,754 (229)

A Phase II Study of Axitinib (AG-013736) in Patients With Incurable Adenoid Cystic Carcinoma

Annals of Oncology, 2016
Ai Ni, D G Pfister, N Katabi
exaly  

Phase II Trial of Dasatinib for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and for Nonadenoid Cystic Malignant Salivary Tumors

Annals of Oncology, 2016
Athanassios Argiris, N F Saba, H J Lenz
exaly  

Expression of KIT (CD117) in Neoplasms of the Head and Neck: An Ancillary Marker for Adenoid Cystic Carcinoma

Modern Pathology, 2003
William C Faquin
exaly  

Adenoid Cystic Carcinoma of the Head and Neck – An Update

Oral Oncology, 2015
Asterios Triantafyllou, Missak Haigentz, Afshin Teymoortash   +2 more
exaly  

Adenoid Cystic Carcinoma of the Prostate

British Journal of Urology, 1986
A M, Gilmour, T J, Bell
openaire   +2 more sources

Analysis of MYB Expression and MYB-NFIB Gene Fusions in Adenoid Cystic Carcinoma and Other Salivary Neoplasms

Modern Pathology, 2011
André Fehr, Göran Stenman, Christopher Moskaluk   +2 more
exaly  

Clinical Review – Breast Adenoid Cystic Carcinoma

Breast, 2012
A Khabir, R O Mirimanoff
exaly  

A Phase II Study of Sunitinib in Recurrent And/Or Metastatic Adenoid Cystic Carcinoma (ACC) of the Salivary Glands: Current Progress and Challenges in Evaluating Molecularly Targeted Agents in ACC

Annals of Oncology, 2012
S J Hotte, S J Hotte, L L Siu
exaly  

Cutaneous Adenoid Cystic Carcinoma

Mayo Clinic Proceedings
David, Schembri-Wismayer, Sounak, Gupta, Lori A, Erickson   +2 more
openaire   +2 more sources

Immunoreactivity for c-Kit and p63 as an Adjunct in the Diagnosis of Adenoid Cystic Carcinoma of the Breast

Modern Pathology, 2005
Eugenio Maiorano, Giancarlo Pruneri, Mauro Giuseppe Mastropasqua   +2 more
exaly